Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Paula Castano, Columbia University
ClinicalTrials.gov Identifier:
NCT00677703
First received: May 12, 2008
Last updated: November 16, 2012
Last verified: November 2012
  Purpose

Teen girls and young women taking birth control pills may forget to take their pills or may stop taking them altogether. This places them at risk for unintended pregnancies. Most young women own cell phones and use them for text messaging. We will test whether contraceptive continuation is affected after six months of daily text message reminders.


Condition Intervention
Contraceptives, Oral
Other: Daily Text Messages

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: The Effect of Text Message Reminders on Contraceptive Continuation, a Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Columbia University:

Primary Outcome Measures:
  • contraceptive continuation [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • change in contraceptive knowledge scores [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 968
Study Start Date: January 2008
Study Completion Date: July 2012
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Standard Care
Participants will receive standard care without daily reminders.
Experimental: Text Messages
Participants will receive a daily text message reminder for 6 months
Other: Daily Text Messages

Text message reminders to take oral contraception daily:

Each text message will be a short educational message listing the benefits of contraceptive use and providing instructions for avoiding common medication errors.

Other Name: Text Messaging

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 24 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • aged <25 years requesting OC as their primary method of contraception
  • currently sexually active or anticipating sexual activity within the next 30 days
  • owns cell phone with text messaging capability

Exclusion Criteria:

  • contraindications to combined hormonal contraception per clinic protocol (e.g., hypertension)
  • previous participation in this study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00677703

Locations
United States, New York
Planned Parenthood Boro Hall
Brooklyn, New York, United States, 11201
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Paula M Castano, MD, MPH Columbia University
  More Information

Publications:
Responsible Party: Paula Castano, Assistant Clinical Professor, Columbia University
ClinicalTrials.gov Identifier: NCT00677703     History of Changes
Other Study ID Numbers: AAAC1600
Study First Received: May 12, 2008
Last Updated: November 16, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Columbia University:
birth control pills
contraception
continuation
text messaging
contraceptive continuation
contraceptive knowledge

Additional relevant MeSH terms:
Contraceptive Agents
Reproductive Control Agents
Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on August 20, 2014